Thus, SGLT1 is obviously a transporter molecule regulated by GLP-2 and its analogs in SBS patients. This evidence concerns the gene SLC5A1 and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.